Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Sawitzki

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|May 29, 2019
Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16<sup>+</sup> Cell SubsetsNadja Stobutzki, Stephan Schlickeiser, Mathias Streitz, et al.
Transplantation|March 7, 2014
Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantationUndine A Gerlach, Georgi Atanasov, Leah Wallenta, et al.
Transplantation|September 9, 2016
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal TransplantationUndine Ariane Gerlach, Maren Klöpfel, Georgi Atanasov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expressionBirgit Sawitzki, Claudio Brunstein, Christian Meisel, et al.
Human Vaccines & Immunotherapeutics|March 6, 2013
Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II studyAnne Flörcken, Joachim Kopp, Antje van Lessen, et al.
Frontiers in Immunology|March 12, 2019
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT PerspectiveAnja Ten Brinke, Marc Martinez-Llordella, Nathalie Cools, et al.
European Journal of Immunology|August 16, 2013
Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatmentUlrike Schliesser, Martin Chopra, Andreas Beilhack, et al.
Cells|January 11, 2024
Pro-Resolving Mediators in Rotator Cuff Disease: How Is the Bursa Involved?Franka Klatte-Schulz, Nicole Bormann, Aysha Bonell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2015
TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 productionSimone Z Vogel, Stephan Schlickeiser, Karsten Jürchott, et al.
Plos One|January 14, 2017
Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept TrialOndrej Viklicky, Petra Hruba, Stefan Tomiuk, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|May 29, 2019
Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16<sup>+</sup> Cell SubsetsNadja Stobutzki, Stephan Schlickeiser, Mathias Streitz, et al.
Transplantation|March 7, 2014
Short-term TNF-alpha inhibition reduces short-term and long-term inflammatory changes post-ischemia/reperfusion in rat intestinal transplantationUndine A Gerlach, Georgi Atanasov, Leah Wallenta, et al.
Transplantation|September 9, 2016
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal TransplantationUndine Ariane Gerlach, Maren Klöpfel, Georgi Atanasov, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expressionBirgit Sawitzki, Claudio Brunstein, Christian Meisel, et al.
Human Vaccines & Immunotherapeutics|March 6, 2013
Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II studyAnne Flörcken, Joachim Kopp, Antje van Lessen, et al.
Frontiers in Immunology|March 12, 2019
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT PerspectiveAnja Ten Brinke, Marc Martinez-Llordella, Nathalie Cools, et al.
European Journal of Immunology|August 16, 2013
Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatmentUlrike Schliesser, Martin Chopra, Andreas Beilhack, et al.
Cells|January 11, 2024
Pro-Resolving Mediators in Rotator Cuff Disease: How Is the Bursa Involved?Franka Klatte-Schulz, Nicole Bormann, Aysha Bonell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 10, 2015
TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 productionSimone Z Vogel, Stephan Schlickeiser, Karsten Jürchott, et al.
Plos One|January 14, 2017
Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept TrialOndrej Viklicky, Petra Hruba, Stefan Tomiuk, et al.
Pageof 14